Tri Chemical Laboratories Inc. (TYO:4369)
Japan
· Delayed Price · Currency is JPY 3,395.00
-25.00 (-0.73%)
Apr 28, 2026, 3:30 PM JST
Tri Chemical Laboratories Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | 2021 - 2017 |
| Cash & Equivalents | 7,280 | 9,439 | 10,497 | 11,137 | 8,034 | Upgrade
|
| Cash & Short-Term Investments | 7,280 | 9,439 | 10,497 | 11,137 | 8,034 | Upgrade
|
| Cash Growth | -22.87% | -10.08% | -5.75% | 38.62% | 373.15% | Upgrade
|
| Accounts Receivable | 4,441 | 5,219 | 4,035 | 4,561 | 3,896 | Upgrade
|
| Other Receivables | 2,068 | - | - | - | - | Upgrade
|
| Receivables | 6,509 | 5,219 | 4,035 | 4,561 | 3,896 | Upgrade
|
| Inventory | 7,866 | 5,975 | 4,022 | 2,740 | 2,150 | Upgrade
|
| Other Current Assets | 1,598 | 823 | 454 | 484 | 306 | Upgrade
|
| Total Current Assets | 23,253 | 21,456 | 19,008 | 18,922 | 14,386 | Upgrade
|
| Property, Plant & Equipment | 17,225 | 10,936 | 9,269 | 8,372 | 8,014 | Upgrade
|
| Long-Term Investments | 6,140 | 4,135 | 3,186 | 4,527 | 5,624 | Upgrade
|
| Other Intangible Assets | 89.57 | 74 | 105 | 134 | 181 | Upgrade
|
| Long-Term Deferred Tax Assets | 352.22 | 342 | 295 | 158 | 82 | Upgrade
|
| Other Long-Term Assets | 214.94 | 1 | 1 | 2 | 1 | Upgrade
|
| Total Assets | 47,275 | 36,944 | 31,864 | 32,115 | 28,288 | Upgrade
|
| Accounts Payable | 2,046 | 969 | 354 | 1,142 | 613 | Upgrade
|
| Accrued Expenses | 147.76 | 126 | 115 | 124 | 113 | Upgrade
|
| Current Portion of Long-Term Debt | 640.2 | 653 | 700 | 785 | 961 | Upgrade
|
| Current Portion of Leases | 122.68 | 105 | 102 | 91 | 90 | Upgrade
|
| Current Income Taxes Payable | 766.04 | 1,295 | 235 | 787 | 800 | Upgrade
|
| Other Current Liabilities | 3,882 | 1,034 | 1,047 | 746 | 888 | Upgrade
|
| Total Current Liabilities | 7,605 | 4,182 | 2,553 | 3,675 | 3,465 | Upgrade
|
| Long-Term Debt | 3,083 | 722 | 1,212 | 1,913 | 2,699 | Upgrade
|
| Long-Term Leases | 280.59 | 296 | 384 | 453 | 532 | Upgrade
|
| Pension & Post-Retirement Benefits | 157.49 | 155 | 143 | 133 | 118 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 62 | 152 | Upgrade
|
| Other Long-Term Liabilities | - | 2 | 3 | 4 | 3 | Upgrade
|
| Total Liabilities | 11,125 | 5,357 | 4,295 | 6,240 | 6,969 | Upgrade
|
| Common Stock | 3,279 | 3,278 | 3,278 | 3,278 | 3,278 | Upgrade
|
| Additional Paid-In Capital | 3,180 | 3,179 | 3,179 | 3,179 | 3,179 | Upgrade
|
| Retained Earnings | 28,670 | 24,291 | 20,304 | 18,809 | 14,626 | Upgrade
|
| Treasury Stock | -2.75 | -2 | -2 | -2 | -1 | Upgrade
|
| Comprehensive Income & Other | 1,024 | 841 | 810 | 611 | 237 | Upgrade
|
| Shareholders' Equity | 36,150 | 31,587 | 27,569 | 25,875 | 21,319 | Upgrade
|
| Total Liabilities & Equity | 47,275 | 36,944 | 31,864 | 32,115 | 28,288 | Upgrade
|
| Total Debt | 4,126 | 1,776 | 2,398 | 3,242 | 4,282 | Upgrade
|
| Net Cash (Debt) | 3,154 | 7,663 | 8,099 | 7,895 | 3,752 | Upgrade
|
| Net Cash Growth | -58.84% | -5.38% | 2.58% | 110.42% | - | Upgrade
|
| Net Cash Per Share | 97.05 | 235.81 | 249.22 | 242.95 | 115.75 | Upgrade
|
| Filing Date Shares Outstanding | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 | Upgrade
|
| Total Common Shares Outstanding | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 | Upgrade
|
| Working Capital | 15,649 | 17,274 | 16,455 | 15,247 | 10,921 | Upgrade
|
| Book Value Per Share | 1112.41 | 972.00 | 848.36 | 796.23 | 656.03 | Upgrade
|
| Tangible Book Value | 36,060 | 31,513 | 27,464 | 25,741 | 21,138 | Upgrade
|
| Tangible Book Value Per Share | 1109.65 | 969.73 | 845.13 | 792.11 | 650.46 | Upgrade
|
| Land | 1,461 | - | - | - | - | Upgrade
|
| Buildings | 10,039 | - | - | - | - | Upgrade
|
| Machinery | 13,804 | - | - | - | - | Upgrade
|
| Construction In Progress | 984.41 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.